Asahi Kasei in $2.21 Billion Tender Offer for ZOLL Medical

Cleary Gottlieb represented Asahi Kasei Corporation in its acquisition through a cash tender offer all of the outstanding common stock of Massachusetts-based ZOLL Medical Corporation, a manufacturer of resuscitation and critical care devices and related software solutions, for $93 per share. The transaction, which is valued at approximately $2.21 billion, was announced on March 12 and closed on April 26.

Asahi Kasei has identified health care as a key strategic sector that will power a new phase of growth for the group, and believes that the acquisition represents a significant milestone in fulfilling its core vision for the health care sector: improving patient quality of life through the creation of innovative technologies and devices for critical care. The acquisition extends the development of Asahi Kasei’s “Health Care for Tomorrow” project, a key focus of which is the resuscitation and critical care sector, an area where ZOLL is already a market leader in the United States and has a strong international market presence.